NKTX compared with RANI: revenue, margins and what each company keeps, and the suppliers and customers both name

NKTXNkarta, Inc.

Mkt capRevenueRevenue

RANIRani Therapeutics Holdings, Inc.

Mkt capRevenueRevenue

Compare

NKTXNkarta, Inc.

RANIRani Therapeutics Holdings, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

NKTX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±25.3%▼−5.28%×0.21

May 13 '26±22.2%▼−6.71%×0.30

Q1 FY26±23.7%▲+0.47%×0.02

Q3 FY25±10.6%▲+2.55%×0.24

RANI1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±35.6%▼−0.23%×0.01

= impliedNKTX realized, solidRANI realized, hatchedOne scale, both sides: full bar = 36%× = |realized| ÷ impliedSource: market data

NKTXNkarta, Inc.

1.73▲+13.08%· post 1.73

Mkt cap$123.9MRevenue—

RANIRani Therapeutics Holdings, Inc.

0.57▲+3.04%· post 0.59

ClosedNov 4 '26

Mkt cap$79.8MRevenue$2MQ2 FY26

Compare

ClosedNov 4 '26

NKTXNkarta, Inc.

RANIRani Therapeutics Holdings, Inc.

1.73▲+13.08%post 1.73

Price

0.57▲+3.04%post 0.59

$123.9M

Mkt cap

$79.8M

—

Revenue

$2MQ2 FY26

NKTX1.73▲+13.08%vsRANI0.57▲+3.04%ClosedNov 4 '26